ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Hot Features

Registration Strip Icon for monitor Monitoree múltiples cotizaciones en tiempo real de los principales intercambios, como la Bolsa de Valores de Londres, NASDAQ, NYSE, AMEX, Bovespa y más.
Marker Therapeutics (delisted)

Marker Therapeutics (delisted) (TPIV)

8.34
0.00
(0.00%)
Cerrado 23 Noviembre 3:00PM
0.00
0.00
(0.00%)
Fuera de horario: -

Herramientas de nivel profesional para inversores individuales.

Estadísticas y detalles clave

Último Precio
8.34
Postura de Compra
7.06
Postura de Venta
8.40
Volume Operado de la Acción
-
0.00 Rango del Día 0.00
0.00 Rango de 52 semanas 0.00
Precio Anterior
8.34
Precio de Apertura
-
Hora
Última hora de negociación
Volumen promedio (3 m)
-
Volumen financiero
-
Precio Promedio Ponderado
-

TPIV Últimas noticias

TapImmune And Marker Therapeutics Announce Successful Closing Of Previously Announced Merger And Financing

TapImmune And Marker Therapeutics Announce Successful Closing Of Previously Announced Merger And Financing - TapImmune Inc. changes name to Marker Therapeutics, Inc. - To Commence Trading on...

TapImmune's HER2/neu-Targeted Breast Cancer Vaccine to be Studied in a Large Phase 2 Immunotherapy Combination Study Funded b...

TapImmune's HER2/neu-Targeted Breast Cancer Vaccine to be Studied in a Large Phase 2 Immunotherapy Combination Study Funded by an $11 Million U.S. Department of Defense Grant Mayo Clinic Receives...

TapImmune to Present at Two Upcoming Investor Conferences

TapImmune to Present at Two Upcoming Investor Conferences PR Newswire JACKSONVILLE, Fla., Sept. 25, 2018 JACKSONVILLE, Fla., Sept. 25, 2018 /PRNewswire/ -- TapImmune Inc. (NASDAQ: TPIV), a...

TapImmune To Present at 2018 Janney Healthcare Conference

TapImmune To Present at 2018 Janney Healthcare Conference PR Newswire JACKSONVILLE, Fla., Sept. 12, 2018 JACKSONVILLE, Fla., Sept. 12, 2018 /PRNewswire/ -- TapImmune Inc. (NASDAQ: TPIV), a...

TapImmune to Participate at Two Upcoming Industry Conferences

TapImmune to Participate at Two Upcoming Industry Conferences PR Newswire JACKSONVILLE, Fla., Aug. 29, 2018 JACKSONVILLE, Fla., Aug. 29, 2018 /PRNewswire/ --TapImmune Inc. (NASDAQ: TPIV), a...

TapImmune Announces Pricing of $70 Million Private Placement

TapImmune Announces Pricing of $70 Million Private Placement Financing Led by New Enterprise Associates (NEA) Financing to Close Concurrently with Close of Merger with Marker Therapeutics PR...

TapImmune to Present at the Jefferies 2018 Global Healthcare Conference

TapImmune to Present at the Jefferies 2018 Global Healthcare Conference PR Newswire JACKSONVILLE, Fla., May 31, 2018 JACKSONVILLE, Fla., May  31, 2018 /PRNewswire/ -- TapImmune Inc. (NASDAQ:...

TapImmune to Present at 2018 Sachs Associates Immuno-Oncology BD&L and Investment Forum

TapImmune to Present at 2018 Sachs Associates Immuno-Oncology BD&L and Investment Forum PR Newswire JACKSONVILLE, Fla., May 30, 2018 JACKSONVILLE, Fla., May 30, 2018 /PRNewswire/ -- TapImmune...

TapImmune to Host Investor Webinar on Thursday, May 24th to Discuss Proposed Merger with Marker Therapeutics and Its Transfor...

TapImmune to Host Investor Webinar on Thursday, May 24th to Discuss Proposed Merger with Marker Therapeutics and Its Transformational T Cell Therapy Platform PR Newswire JACKSONVILLE, Fla., May...

TapImmune Expands Scientific Advisory Board with Cancer Immunotherapy Pioneers James P. Allison, Ph.D., and Padmanee Sharma, ...

TapImmune Expands Scientific Advisory Board with Cancer Immunotherapy Pioneers James P. Allison, Ph.D., and Padmanee Sharma, M.D., Ph.D., from the MD Anderson Cancer Center PR...

Período †Variación(Ptos)Variación %AperturaPrecio MáximoPrecio MínimoAvg. Vol. diarioPrecio Promedio Ponderado
10000000CS
40000000CS
120000000CS
260000000CS
520000000CS
1560000000CS
2600000000CS

Movimientos

Ver todo
  • Volumen
  • % Mayores Alzas
  • % Mayores Bajas
SímboloPrecioVol.
PDYNPalladyne AI Corporation
US$ 4.59
(129.50%)
83.07M
QMCOQuantum Corporation
US$ 9.11
(126.62%)
39.48M
NANano Labs Ltd
US$ 8.26
(89.02%)
2.03M
XCURExicure Inc
US$ 18.60
(71.27%)
4.59M
SKKSKK Holdings Limited
US$ 1.75
(59.09%)
107.47M
AMIXAutonomix Medical Inc
US$ 6.21
(-54.07%)
946.09k
CETXCemtrex Inc
US$ 0.1146
(-41.74%)
24.39M
MSWMing Shing Group Holdings Ltd
 5.90
(-35.52%)
417.08k
RMSGReal Messenger Corporation
US$ 3.09
(-26.25%)
313.51k
ENSCEnsysce Biosciences Inc
US$ 0.4414
(-25.49%)
4M
ELABElevai Labs Inc
US$ 0.0201
(-0.50%)
425.38M
NVDANVIDIA Corporation
US$ 141.95
(-3.22%)
236.51M
SMCISuper Micro Computer Inc
US$ 33.15
(11.62%)
159.61M
VRPXVirpax Pharmaceuticals Inc
US$ 0.5501
(-6.72%)
159.39M
SOUNSoundHound AI Inc
US$ 8.24
(18.05%)
107.91M
Vulcanized Crawler Vulcanized Crawler 5 minutos hace
evidently someone does not know what research, due diligence, education, reading the newspaper, or going to the library is all about
XLMUSD
kund kund 5 minutos hace
What promotion? Anavex has CMO, who designed the failed Rett trial, likely did so under the directive of TGD. It's hard to imagine that employees at Anavex have the freedom to provide constructive input on trials or regulatory filings. This seems to be a one-man operation where TGD makes all the dec
AVXL
Kool Aid Man Kool Aid Man 5 minutos hace
No..to bust crooks and scammers. If that saves someone from getting screwed then all the better
BDGR
getmoreshares getmoreshares 6 minutos hace
interesting video from Kaboomracks https://www.youtube.com/watch?v=smviPfe1eYE
CGAC
DarkPool DarkPool 6 minutos hace
People should go back and read you posts over the years also. Then they'll see who the real clown is and whose the real OG is. It's all archived and they'll see who the smart one is😘
XRPUSD
frrol frrol 7 minutos hace
It's an administrative task, to be sure. The possible shortcomings causing rejection, however, are not just an easily fixed "you missed a section" but also not having data for a required section. The latter problem can range from the data simply not being in acceptable form (likely fixable) to not h
AVXL
georgebailey georgebailey 8 minutos hace
If I know what I think I own all of the listed combo candidates will license and whomever goes first takes the advantage over the others.
NWBO
rooster rooster 8 minutos hace
He blew her draws off where it really counted! The only vote that counts the electoral votes baby! Get over it stop trying to make yourself feel better by lying to yourself
OMOLIVES OMOLIVES 8 minutos hace
No...I didn't and I wouldn't have voted for OZ if I were still living in PA. I don't dislike him...I just preferred John as a lawmaker. And I have no problem with Oz's appointment if he secures it. I have no problem with a heart surgeon being nominated. So tell me about your opinion on Chiquita.
bwrbad bwrbad 9 minutos hace
real estate market is waking up . All of the company in this space was hurting, but OPEN was punished badly for not being aligned with you know who and what - OPEN is a good company and foresee it going past $10 in a heartbeat.
OPEN
crazy horse 0 crazy horse 0 9 minutos hace
Another great move

Trump brings back former aide Sebastian Gorka, ex-State Department official Alex Wong to serve in admin

President-elect Trump on Friday announced that former State Department official Alex Wong will be appointed assistant to the president and principa
Louie_Louie Louie_Louie 10 minutos hace
Anyone know what's happened with Tim Howard? You'd think he'd be all over this since Trump won, but no one has posted a single thing from him that's current in a long time. Anyone still following his blog?
Oleblue Oleblue 10 minutos hace
NVDA to Hit "$800 in 2030," Earnings & DOGE Show Why

https://youtu.be/wJiMnEsd9sQ

https://api.wsj.net/api/kaavio/charts/big.chart?nosettings=1&symb=NVDA&uf=32&type=4&size=4&sid=129254&style=330&freq=2&entitlementtoken=0c33378313484ba9b46b8e24ded87dd6&time=9&rand=4802756
NVDA
powerwalker powerwalker 11 minutos hace
... and your point is? froll told an untruth, twice, knowingly about the filing dates and your response does what to clarify. Go talk to your FUD-buddy about getting his story straight about Anavex's filings.
AVXL
oldmystic oldmystic 13 minutos hace
Husky,
Clean the cobwebs out ya attic.
Mystic
AVXL
DarkPool DarkPool 13 minutos hace
Lmao. Feel free to go back and read the posts. All documented for many years. I remember you! You weren't the smart one now were you. 
XRPUSD
CrossFireTrader CrossFireTrader 14 minutos hace
I don't anymore but I will subscribe again so I can share something privately with you 
GDVM
OMOLIVES OMOLIVES 16 minutos hace
lol....YES. And it's a good thing.
Kam8 Kam8 17 minutos hace
15B only......I would like to cry😢 😭.   My dream is at least $15 😢 😭 
NWBO
Slojab Slojab 19 minutos hace
You can't save lives, Frank, if you can't sell the product.

Enough talk.
SANP
HJ72 HJ72 20 minutos hace
Everyone get their Schedule 14C in the mail? AS will be reduced to 50 million and another reverse split to outstanding shares of common stock coming...the first one pretty much wiped us out OTC show there's only 4,721 shares held at DTC. So another RS charge otw WTF.
DTC
buyittradeit buyittradeit 20 minutos hace
$SPY chart and outlook https://x.com/APEXPENNYSTOCKS/status/1860506470820745378 link
SPY
Ray_137 Ray_137 20 minutos hace
Plan 6 was not approved, that's why Rosen made plan 7 and Judge finally approved plan7.
COOP
12x 12x 20 minutos hace
Under SEC rules, the timing of a company’s 10-K filing depends loosely on its MC at the end of Q2. Companies with an MC above $700M are classified as large accelerated filers and have 60 days to file, for AVXL it's the end of November. For those below $700M, the deadline extends beyond 60 days, into
AVXL

Su Consulta Reciente

Delayed Upgrade Clock